Table 5 Response to treatment with etoposide referring to response to previous platinum treatment (n=18)

From: Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer

 

CR

PR

NC

PD

NE

Platinum sensitive

4

2

3

  

Platinum resistant

 

1

4

2

2

  1. CR=complete remission; PR=partial remission; NC=no change; PD=progressive disease; NE=not evaluable.
Back to article page